Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dennis Podlesak
AddedFeb 15, 2024
UpdatedMay 31, 2026
Dennis Podlesak

Dennis Podlesak

Board Member, Kalidex Pharmaceuticals

CrunchbaseThe Org

Dennis Podlesak's Career

Kalidex Pharmaceuticals
Kalidex Pharmaceuticals

Menlo Park, CA, US

Board Member· Board
Syndax Pharmaceuticals
Syndax Pharmaceuticals

Waltham, MA, US

Board Member· Board
RightCare Solutions
RightCare Solutions

Horsham, PA, US

Board Member· Board
Adastra Pharmaceuticals
Adastra Pharmaceuticals

San Diego, CA, US

Board Member· Board
Adynxx
Adynxx

San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dennis Podlesak's Career

Kalidex Pharmaceuticals
Kalidex Pharmaceuticals
$15M02010Menlo Park, CA, US
Board Member· Board

Leadership at Kalidex Pharmaceuticals

Brent AhrensBrent AhrensBoard Member
James GeJames GeFounder

Similar to Kalidex Pharmaceuticals

Nexcida TherapeuticsNexcida TherapeuticsMenlo Park, CA, USAntibiotics, Therapeuticsest. 2014Nexcida TherapeuticsMenlo Park, CA, US · est. 2014

Innovative Menlo Park-based medical organization developing novel antibiotics for drug-resistant bacteria.

Seed · $2.8M50
Bioxiness PharmaceuticalsBioxiness PharmaceuticalsHercules, CA, USAntimicrobial Compoundsest. 2007Bioxiness PharmaceuticalsHercules, CA, US · est. 2007

Bioxiness Pharmaceuticals: A CA-based firm developing novel antimicrobial compounds for severe infections.

Pre-Seed · $804.6k5
Recida TherapeuticsRecida TherapeuticsMenlo Park, CA, USPharmaceuticalsest. 2016Recida TherapeuticsMenlo Park, CA, US · est. 2016

Recida Therapeutics, Inc.: A biopharmaceutical firm developing treatments for antibiotic-resistant infections.

Series A · $18.6M5
Cardeas PharmaCardeas PharmaSeattle, WA, USAntibiotics, Pharmaceuticalsest. 2010Cardeas PharmaSeattle, WA, US · est. 2010

Cardeas Pharma: Specializing in developing inhaled antibiotics for respiratory infections.

Series B · $80M30
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Public$803.6M1072005Waltham, MA, US
Board Member· Board

Leadership at Syndax Pharmaceuticals

Michael A. MetzgerMichael A. MetzgerBoard Member
Art PappasArt PappasBoard Member
Pierre LegaultPierre LegaultBoard Member
Jennifer JarrettJennifer JarrettBoard Member
Eckard WeberEckard WeberBoard Member
Peter OrdentlichPeter OrdentlichFounder
RightCare Solutions
RightCare Solutions
Series B$10.8M312011Horsham, PA, US
Board Member· Board

Leadership at RightCare Solutions

Eric HeilEric HeilFounder
Eric M HeilEric M HeilCEO

Similar to RightCare Solutions

Continual Care SolutionsContinual Care SolutionsPittsford, NY, USHealthcare, Softwareest. 2017Continual Care SolutionsPittsford, NY, US · est. 2017

Continual Care Solutions: Integrating social determinant care with clinical care for at-risk populations, using cloud-based software to optimize well-being and operational success.

Angel · $50k12
Forward Health GroupForward Health GroupMadison, WI, USHealthcare Softwareest. 2009Forward Health GroupMadison, WI, US · est. 2009

Forward Health Group: Pioneering value-based care software for successful healthcare transitions.

Series A · $10.7M33
CareBridgeCareBridgeNashville, TN, USHealthcare Softwareest. 2019CareBridgeNashville, TN, US · est. 2019

CareBridge offers tech and services to aid health plans and states in long-term care support.

Series C · $182.4M343
CarePort HealthCarePort HealthCare Coordination, Discharge PlanningCarePort Health

Healthcare networking company

Angel · $6k
Adastra Pharmaceuticals
Adastra Pharmaceuticals
$85M02005San Diego, CA, US
Board Member· Board

Leadership at Adastra Pharmaceuticals

Evgeny ZaytsevEvgeny ZaytsevBoard Member
Kim KamdarKim KamdarBoard Member
Ralph ChristoffersenRalph ChristoffersenBoard Member
Chris ChristoffersenChris ChristoffersenBoard Member
Alain SchreiberAlain SchreiberBoard Member
Chris LeMastersChris LeMastersFounder

Similar to Adastra Pharmaceuticals

Adhera TherapeuticsAdhera TherapeuticsDurham, NC, USPharmaceuticalsest. 1983Adhera TherapeuticsDurham, NC, US · est. 1983

US-based Adhera Therapeutics develops specialty pharmaceuticals for inflammatory diseases, hypertension, and cancer.

Seed · $3.2M37
Tigris PharmaceuticalsTigris PharmaceuticalsBonita Springs, FL, USCancer Treatmentsest. 2005Tigris PharmaceuticalsBonita Springs, FL, US · est. 2005

Tigris Pharmaceuticals: Innovating biopharmaceutical solutions for cancer and other medical needs.

Series C · $32.5M6
Adventris PharmaceuticalsAdventris PharmaceuticalsSan Francisco, CA, USCancer Vaccinesest. 2022Adventris PharmaceuticalsSan Francisco, CA, US · est. 2022

Adventris Pharmaceuticals, a San Francisco-based firm, specializes in developing cancer vaccines.

Pre-Seed · $500k6
Novita PharmaceuticalsNovita PharmaceuticalsNew York City, NY, USCancer Drugsest. 2010Novita PharmaceuticalsNew York City, NY, US · est. 2010

Novita Pharmaceuticals: Developing and providing cancer-treatment drugs since 2010, based in New York.

Series A · $8.5M7
Adynxx
Adynxx
$23.5M62007San Francisco, CA, US
Board Member· Board

Leadership at Adynxx

Julien MametJulien MametBoard Member
Stan AbelStan AbelBoard Member
Heath LukatchHeath LukatchBoard Member
Greg FlesherGreg FlesherBoard Member
Rick OrrRick OrrBoard Member

People Similar to Dennis Podlesak

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · KakaoBill MillerBill MillerFounder · PV VenturesAshok KrishnamoorthyAshok KrishnamoorthyCo-Founder · AxalumeScott KannryScott KannryCo-Founder · AxioAdrian AdamsAdrian AdamsBoard Member · AcelRx PharmaceuticalsBassam Al-KhalidiBassam Al-KhalidiCo-Founder · AxiadGopi SirineniGopi SirineniCEO · Axiado